Skip to the main content.


Umer Raffat

Fundamental Research Analyst

Umer Raffat is a Senior Managing Director at Evercore ISI and heads our large cap therapeutics effort spanning Large Biotech, Pharmaceuticals-major and Specialty Pharmaceuticals.

He has ranked #1 in Institutional Investor’s Specialty Pharmaceuticals category for the last two years, including in 2015 – his first year covering the sector. Previously, he ranked #1 Rising Star Analyst two years in a row – once in Specialty Pharma and once in Biotech.

Mr. Raffat started his equity research career covering Biotech for 5 years under #1 ranked Dr. Mark Schoenebaum. Mr. Raffat and Dr. Schoenebaum moved to Evercore ISI from Deutsche Bank in 2010. Mr. Raffat has an undergrad in biology from University of Texas at Arlington and a Masters from Harvard School of Public Health.

< Back to Team

Clients First,


Intern, Analyst and Associate Positions

Evercore's robust programs for undergraduate and graduate students offer career opportunities we believe are unmatched in the industry, including training, mentorship activities, and hands-on transaction experience...
more >

Experienced Hires

Evercore's rapid global expansion and growing industry sector coverage requires that we consistently seek and hire exceptionally-talented senior executives to join our team...
more >